PRESS-RELEASE ·Filed Oct 22, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
Denali Therapeutics Inc. announced it will report its Q3 2026 results on November 3, 2026.
Key Facts
- Denali Therapeutics Inc. announced it will report its Q3 2026 results on November 3, 2026.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3386869 |
13 reports for DNLI
60% Hit rate @ T+1 Went positive at some point 4 of 5 best @ T+60▲ +23.19%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 5d ago | Press Release | $18.66 | awaiting T+1 | — | $19.22 (+3.00%) |
Sep 9, 2026 6w ago | Insider Cluster | $21.40 $21.09 | ▼ −1.45% | ▼ −2.30% | $19.22 (−10.19%) |
Sep 4, 2026 7w ago | Insider Cluster | $22.08 $21.57 | ▼ −2.31% | ▼ −1.84% | $19.22 (−12.95%) |
Aug 6, 2026 11w ago | 8-K | $24.83 $25.00 | ▲ +0.68% | ▲ +0.71% | $19.22 (−22.59%) |
Jul 27, 2026 13w ago | Press Release | $24.05 | awaiting T+1 | — | $19.22 (−20.08%) |
Jun 18, 2026 18w ago | 8-K | $23.31 $24.05 | ▲ +3.17% | ▲ +3.49% | $19.22 (−17.55%) |
Jun 18, 2026 18w ago | Press Release | $23.31 $24.05 | ▲ +3.17% | ▲ +3.49% | $19.22 (−17.55%) |
Jun 11, 2026 19w ago | Institutional Cluster | $21.02 $21.66 | ▲ +3.04% | ▲ +2.50% | $19.22 (−8.56%) |
May 21, 2026 22w ago | Press Release | $18.64 $19.38 | ▼ −3.97% | ▼ −3.38% | $19.22 (−3.11%) |
May 7, 2026 24w ago | Press Release | $19.62 $19.67 | ▲ +0.25% | ▲ +0.02% | $19.22 (−2.04%) |
Showing 10 of 13
US Market Status
Market Closed — Opens in 9h 25m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers